Home Newsfeeds Benitec Biopharma Receives Notice Of Allowance For Its US Patent Application 16/642,967 Titled “Adeno-associated Virus With Modified Phospholipase Domain”.

News

Benitec Biopharma Receives Notice Of Allowance For Its US Patent Application 16/642,967 Titled “Adeno-associated Virus With Modified Phospholipase Domain”.

https://patentcenter.uspto.gov/applications/16642967/ifw/docs

byBenzinga Newsdesk

July 26, 2022

1 minute read

https://patentcenter.uspto.gov/applications/16642967/ifw/docs

News

EEIQ Announces Operations Update For Davis College; Davis College’s Key Strides In Recruitment And Programming Expected To Result In Increased Revenue Generation

By Benzinga Newsdesk

October 10, 8:48 AM

Davis College's Key Strides in Recruitment and Programming Expected to Result in Increased Revenue GenerationMIDDLETOWN, Ohio, Oct. 10, 2023 /PRNewswire/ -- EpicQuest Education Group International Limited

EEIQ

News

Addex Therapeutics Regains Nasdaq Listing Compliance With Minimum Bid Price Requirement

By Benzinga Newsdesk

February 9, 3:28 AM

Addex Therapeutics (NASDAQ:ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced notification from The Nasdaq Stock Market LLC

ADXN

HC Wainwright & Co. Reiterates Buy on Armata Pharmaceuticals, Maintains $7 Price Target

By Benzinga Newsdesk

March 7, 5:42 AM

HC Wainwright & Co. analyst Joseph Pantginis reiterates Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 price target.

ARMP

GlobalFoundries To Scoop $1.5 Billion In CHIPS Act Grants: What It Means For Semiconductor Sector

By Neil Dennis

February 19, 12:39 PM

Around 170 companies have applied for grants from the Commerce Department, including Intel.

AMD

Benitec Biopharma Receives Notice Of Allowance For Its US Patent Application 16/642,967 Titled “Adeno-associated Virus With Modified Phospholipase Domain”.

Related Posts

EEIQ Announces Operations Update For Davis College; Davis College’s Key Strides In Recruitment And Programming Expected To Result In Increased Revenue Generation

Addex Therapeutics Regains Nasdaq Listing Compliance With Minimum Bid Price Requirement

HC Wainwright & Co. Reiterates Buy on Armata Pharmaceuticals, Maintains $7 Price Target

GlobalFoundries To Scoop $1.5 Billion In CHIPS Act Grants: What It Means For Semiconductor Sector